Increased skin disorders, such as psoriasis, eczema, and vitiligo, have led to the phototherapy lamps segment expansion. Besides, an increased awareness of phototherapy has influenced the growth of this segment as an available non-invasive treatment option.
These lamps emit controlled ultraviolet light to treat skin disorders with a maximum safety option than that for systemic medications. The market is expected to grow to USD 3.7 billion by 2025 and reach USD 6.8 billion by 2035, estimated to grow at a compound annual growth rate (CAGR) of 6.2% during the period.
Development in UV lamp technology, such as narrowband UVB and excimer lamps, has increased the threshold of efficacy defined for any given treatment. These improvements are being seen with better patient compliance.
Furthermore, increased consumer uptake of home phototherapy devices is another benefit to this market segment due to improved patient convenience. Thus, there will be a noticeable increase in demand for R&D because of the rapidly growing elderly population, which is more prone to skin diseases, thereby increasing demand for the global market.
Market Metrics
| Metric | Value |
|---|---|
| Market Size (2025E) | USD 3.7 Billion |
| Market Value (2035F) | USD 6.8 Billion |
| CAGR (2025 to 2035) | 6.2% |
Owing to their promissory advances in awareness, reimbursement policies, and very sound health care infrastructure, North America leads this market in phototherapy lamps. Extensive clinical and home use of phototherapy devices exists in the United States and Canada. Continual growth results from investments made in dermatology research, as well as from increased frequency of skin conditions.
Growth in Europe is primarily being driven by an increasing incidence of chronic skin disorders and healthcare advancement. Countries like Germany, the UK, and France are promising markets for innovative phototherapy solutions. Government incentives directed at non-invasive treatments and increasing patient preference for home therapies are further contributing to the growth of this market.
The fastest increase may happen with the phototherapy lamps market in Asia-Pacific. The demand for such lamps in China, India, Japan, and Australia is driven by increased awareness regarding phototherapy treatment, expansion of access to healthcare, and the development of diagnostic facilities. In addition, this market is growing due to increasing disposable income in this region and pro-people government healthcare initiatives.
High Initial Cost and Lack of Awareness
The therapeutic lamp market still faces barriers in initial costs for advanced devices and limited patient awareness in developing countries. Some patients have an aversion toward phototherapy due to the side effects that they attribute to UV exposure. There is a lack of trained professionals who are able to apply and promote phototherapy, further hindering penetration of this market.
Technological Innovations and Growing Homecare Demand
An innovative run-through to patient convenience and adherence comes via innovative workable and wearable phototherapy devices. Home-based phototherapy options have bright prospects, especially in the countryside or in areas considered neglected. The trend of combining phototherapies with topical or systemic therapies provides fresh avenues for growth.
The phototherapy lamps market exhibited consistent growth from 2020 to 2024, owing mainly to end-users such as hospitals and clinics. Anticipating future developments, narrowband UVB lamps have replaced the old-generation broadband UVB ones as better therapeutic agents with an improved safety profile.
The expected growth trajectory for 2025 to 2035 envisages a spurt in growth with the burgeoning demand for phototherapy lamps that are wearable and portable. Such integration with smart technologies and digital health platforms will provide personalized treatment regimens and remote monitoring.
Moreover, the additional expanding clinical applications apart from dermatology constitute a broader market scope regarding neonatal jaundice and mood disorders. Manufacturers collaborating with healthcare providers are expected to increase access and affordability globally.
| Key Dimensions | 2020 to 2024 |
|---|---|
| Lamp Technology | Broadband UVB, narrowband UVB |
| Application Focus | Skin disorders (psoriasis, eczema, vitiligo) |
| Adoption Geography | North America, Europe primarily |
| Key Drivers | Rising skin disease prevalence, hospital use |
| Device Portability | Mostly stationary devices |
| User Base | Dermatology clinics and hospitals |
| Regulatory Focus | Device safety and efficacy |
| Market Segmentation | By lamp type and application |
| Key Dimensions | 2025 to 2035 |
|---|---|
| Lamp Technology | Wearable devices, excimer lamps, LED-based lamps |
| Application Focus | Expanded uses (neonatal jaundice, mood disorders) |
| Adoption Geography | Rapid expansion in Asia-Pacific, Latin America |
| Key Drivers | Home-based therapy demand, technological advances |
| Device Portability | Portable, wearable, and smart phototherapy lamps |
| User Base | Patients and homecare providers |
| Regulatory Focus | Smart device integration and data privacy |
| Market Segmentation | By application, technology, and end-user |
The USA healthcare industry adopts the newest phototherapy technologies actively, given the thorough regulations enforced by the FDA to ensure safety and efficacy. Additionally, investments in dermatology laboratories and the growing demand from cosmetic clinics and hospitals are also drivingly contributing to the growth of this market.
The convenience and efficacy of phototherapy lamps to combat neonatal jaundice accentuate demand further. Growing availability of knowledge among the public regarding skin health and developments in technology such as LED-based phototherapy devices drive the market. The geriatric segment worldwide is growing, and as skin-related ailments increase with age, demand rises continuously.
| Country | CAGR (2025 to 2035) |
|---|---|
| United States | 6.3 % |
The phototherapy lamps market in the UK is on its way to steady growth as more and more patients are preferring those safer and effective ways for skin treatment. NHS is increasingly emphasizing the dermatology care, and a greater number of people are aware of beneficial phototherapy to improve usage rates.
The MHRA makes all these phototherapy devices meet the highest standards of safety and quality, thereby improving confidence among consumers. Rise in the incidence of chronic skin diseases and growing applications of cosmeceuticals are driving this market.
Home-based phototherapy solutions are becoming popular since most patients usually want treatment as simple and convenient as possible. The increase in healthcare spending will propel the growth of already busy dermatology centres. This market in the UK is boosted further by research and innovations in improving the efficiency, usability, and comfort of the patient with the LED phototherapy technology.
| Country | CAGR (2025 to 2035) |
|---|---|
| United Kingdom | 6.5 % |
Phototherapy lamps in the European Union have been growing steadily for the last few years, owing to an increasing number of skin disorders and greater acceptance of non-invasive treatment methods. By strictly controlling all aspects of Phototherapy within the EMA to ensure safety and performance standards, Germany, France, and Italy are spearheading market acceptance, given their advanced healthcare systems and greater awareness of dermatology. Demand for phototherapy is there to treat a variety of disorders.
Cosmetic phototherapy treatments have gained enormous popularity, and at the same time, portable devices and home-use products are becoming trendy-the demand for phototherapy lamps will continue growing.
The future of the market regarding skin health will be bright. The increasing knowledge of the public regarding the benefits of phototherapy and the evolution of reimbursement policies into being will sponsor growth opportunities in the regional market.
| Country | CAGR (2025 to 2035) |
|---|---|
| European Union | 6.4 % |
The forecast for the Japanese phototherapy lamp market remains moderate to strong in the future due to a meteoric rise in the incidence of skin disorders and the rapidly expanding aged population afflicted with skin diseases. In Japan, phototherapy is administered under the purview of the Ministry of Health, Labour and Welfare, which is instrumental in drafting safety standards.
The growth of the market for phototherapy lamps owes, rather, to public investment in advanced healthcare systems and technology, and huge aging populations suffering from skin diseases. The demand for phototherapy lamps was observed to witness an uptrend against the background of rising awareness among practitioners and patients regarding the procedure's safety and effectiveness. The growing inclination toward the use of home care phototherapy lamps in addition to developed dermatology clinics has been able to contribute positively to the market growth.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 6.6 % |
In South Korea, the growth of phototherapy lamps is observed steadily with the increase in dermatological patients and alongside the rising demand for cosmetic dermatology. Considering all the regulations established under the MFDS, safety and quality concerns are amply taken care of by imposing such conditions on electronic devices that further enhance consumer confidence.
South Korea's advanced technological infrastructure pushes the innovative design of phototherapy lamps, for example, LED technology enhances efficiency toward better patient care and user satisfaction. However, on the contrary, the increasing demand from an inclination of patients for home-use phototherapy equipment is another factor promoting the sales of these devices.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 6.5 % |
LED Lamps to Lead the Market
| Product Type | Market Share |
|---|---|
| LED | 53.6% |
LED phototherapy lamps are predicted to secure up to 53.6% of a dominant market share in 2025. An increase in the acceptance of LED technology is due to its energy efficiency along with longer life, while the delivery of light wavelengths directed toward certain treatment areas is critical for an effective phototherapy session.
LEDs emit light uniformly, minimizing the amount of heat, thus protecting the patient without causing discomfort during the treatment sessions. For this reason, they have recently enjoyed increased development to improve portability and customization design, making it possible to be used at home or at the clinic.
Moreover, LED lamps are preferred due to being easily tuned for specific wavelengths required in treating various dermatological conditions. They are also environment friendly, which is being a watershed reason for adoption by practitioners considering making treatment decisions on economic feasibility.
In comparison to normal UV and halogen lamps, LEDs offer considerably reduced operational power consumption and maintenance costs that become a boon for clinics and hospitals wishing to further curtail their operational costs. The aggregate of these reasons is the increasing demand for LED phototherapy lamps all across the globe.
Phototherapy lamps using UV radiation are the most abundant with regard to the market share available since they are linked to effective treatment with skin diseases such as psoriasis and vitiligo, they are not used much due to the fact that they generate copious amounts of heat and have adverse effects when compared to LEDs. Halogen lamps are still used for this purpose but, due to inefficient energy consumption and shorter lifetime, their application is in decline against LEDs.
Psoriasis Treatment to Dominate the Market
| Application | Market Share |
|---|---|
| Psoriasis | 39.8% |
It is anticipated that the segment psoriasis will lead the phototherapy lamps market by holding 39.8% of the market share by 2025. It is chronic inflammatory skin disorder affecting millions worldwide and demands therapeutic options. Phototherapy with UVB and LED-based devices in particular are commonly used deliver relief from symptoms through reduced inflammation and slowed skin cell proliferation.
Increasing cases of psoriasis and rising awareness regarding non-invasive treatment modalities are some driving factors for this application area. Moreover, growing inclination of patients towards alternatives of systemic medicines and steroids are expected to boost demand for phototherapy. Healthcare providers are expanding services of phototherapy in dermatology clinics and hospitals because of its efficacy and safety.
Vitiligo is another important application area for phototherapy lamps following psoriasis. Light targeted at the affected areas stimulates pigment production in the skin, making it possible for the skin to achieve its normal colour.
That and continuous improvements in the types of lamp have made treatments much more effective. Other emerging segments that continue to experience healthy growth are acne treatment and jaundice in new-borns, fuelled by increasing patient populations and widening access to specialized phototherapy devices.
The phototherapy lamps market is steadily growing between the years of 2025 to 2035 owing to rise in number of skin disorders such as psoriasis and eczema and rise in demand for non-invasive treatment options. Innovations in energy efficient LEDs, portable phototherapy devices, as well as smart monitoring systems have redefined patient care in clinical as well as home scenarios.
Integration of IoT and mobile connectivity has had a colossal impact on customizing and monitoring phototherapy treatment solutions. In addition, increasingly dermatology clinics and hospitals worldwide are gaining fame for phototherapy lamps awareness regarding light induced therapies is on rise, and health care practitioners are emphasizing safe harmless treatments.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| Philips Healthcare | 21-25% |
| Daavlin Group, Inc. | 17-21% |
| National Biological Corporation | 14-17% |
| Waldmann GmbH & Co. KG | 10-13% |
| Other Companies (combined) | 28-32% |
| Company Name | Key Offerings/Activities |
|---|---|
| Philips Healthcare | In 2024, Philips launched a new energy-efficient LED phototherapy lamp featuring wavelength control for enhanced skin treatment. In 2025, the company plans to introduce an app-integrated system to support treatment tracking and remote guidance. |
| Daavlin Group, Inc. | In 2024, Daavlin released portable home-use UV phototherapy devices for chronic skin conditions. In 2025, the company will roll out upgraded safety-focused devices with customizable exposure settings. |
| National Biological Corporation | In 2024, National Biological introduced a neonatal-specific phototherapy device offering high-precision spectral control. In 2025, the company aims to expand into multi-wavelength systems to support dermatology clinics. |
| Waldmann GmbH & Co. KG | In 2024, Waldmann unveiled a clinical-grade full-body phototherapy lamp with improved light uniformity. In 2025, they plan to integrate IoT connectivity to facilitate device performance monitoring and usage analytics. |
Key Company Insights
Philips Healthcare (21-25%)
Philips Healthcare leads the phototherapy segment with smart, efficient solutions for skin and neonatal care. Their commitment to energy savings, precision light therapy, and remote monitoring tools ensures strong adoption across hospitals and homes.
Daavlin Group, Inc. (17-21%)
Daavlin is known for safe, easy-to-use phototherapy systems designed for home and clinical use. Their emphasis on user control and compact design has made them a trusted provider for long-term skin condition management.
National Biological Corporation (14-17%)
National Biological provides advanced light therapy devices for both dermatological and neonatal applications. Their ongoing development in multi-spectrum systems expands therapeutic applications and offers versatility to medical professionals.
Waldmann GmbH & Co. KG (10-13%)
Waldmann is recognized for clinical-grade phototherapy systems emphasizing light precision and durability. Their push toward digital integration aligns with hospitals’ growing need for connected care infrastructure.
Other Key Players (28-32% Combined)
The overall market size for the phototherapy lamps market was USD 3.7 billion in 2025.
The market is expected to reach USD 6.8 billion in 2035.
Demand will be driven by increasing prevalence of skin disorders, rising awareness about phototherapy benefits, advancements in lamp technology, and growing adoption in healthcare facilities.
The top 5 contributing countries are USA, UK, Europe, Japan, and South Korea.
The LED segment is expected to lead the market due to its effectiveness in treating various skin conditions.
Explore Therapeutic Device Insights
Phototherapy Lamps Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
